AMID is an apoptosis-inducing factor (AIF)-homologous and mitochondria-associated protein that has been implicated in caspase-independent apoptosis. Transcription of human AMID gene is upregulated by p53 and downregulated in tumors in comparison to their matched normal tissues, suggesting the possibility that AMID is involved in the downstream effects of p53. To investigate the physiological functions of AMID, we generated AMID-deficient mice by gene targeting. AMID-deficient mice are viable and fertile, develop normally and lack obvious phenotypic changes compared to wild-type mice up to 1 year old. AMID À/À mice up to 1 year old have no spontaneous tumors and show similar fibrosarcoma incidence after MCA inoculation compared to wild-type mice. AMID À/À embryonic fibroblasts exhibit normal proliferation but slightly increased resistance to genotoxininduced growth arrest. These findings suggest that AMID is not required for normal development and p53-mediated tumor suppression.
Introduction
The p53 gene is one of the most frequently mutated genes in a wide variety of tumor types (Hansen and Oren, 1997; Levine, 1997; Giaccia and Kastan, 1998; Prives and Hall, 1999) . The loss of wild-type p53 activity contributes to tumor development by removing important controls on cell cycle progression, apoptosis and maintenance of genomic integrity (Hansen and Oren, 1997; Levine, 1997; Giaccia and Kastan, 1998; Prives and Hall, 1999) . The limited developmental abnormalities associated with the majority of p53 À/À mice indicate that p53 is dispensable for apoptotic processes occurring during normal embryo development. However, under conditions of cellular stress that endanger the integrity of the genome, p53 becomes crucial in restricting inappropriate cell proliferation (Hansen and Oren, 1997; Levine, 1997; Giaccia and Kastan, 1998; Prives and Hall, 1999) . Under physiological conditions, the p53 tumor suppressor protein is present at a low level because of a short half-life due to rapid turnover mediated by ubiquitination and proteolysis. Following DNA damage, p53 rapidly accumulates and becomes an active transcription factor to activate transcription of a set of downstream genes. The p53-responsive genes identified so far include those involved in cell cycle control, senescence and apoptosis, such as p21, GADD45, 14-3-3, Bax, Fas, DR5/KILLER, Noxa and PUMA, among others (Hansen and Oren, 1997; Levine, 1997; Giaccia and Kastan, 1998; Prives and Hall, 1999) .
Apoptosis is one of the fundamental processes in all metazoans. It is widely believed that mitochondria are integrators of the cell death machinery and caspases are the central executioners of apoptosis (Green and Reed, 1998; Hengartner, 2000; Wang, 2001) . Upon stimulation by various death signals, the outer membrane of mitochondria is permeabilized, resulting in the release to the cytosol of death factors including cytochrome c and Smac/DIABLO (Liu et al., 1996; Du et al., 2000; Verhagen et al., 2000) . These death factors activate caspases through distinct mechanisms and eventually lead to apoptosis. In addition to the classic apoptotic pathways, studies have demonstrated that cytochrome c-, Apaf-1-, or caspases-deficient cells can still undergo apoptosis (Kuida et al., 1996; Cecconi et al., 1998; Hakem et al., 1998; Yoshida et al., 1998; Li et al., 2000) . In addition, apoptosis induced by some stimuli cannot be inhibited by the pan-caspase inhibitor z-VAD-fmk (Amarante-Mendes et al., 1998; Bidere and Senik, 2001 ). These studies suggest that caspase-independent apoptotic pathways exist.
AIF is a flavoprotein normally present in the intermembrane space of mitochondria (Susin et al., 1999) . Upon stimulation by certain death signals, AIF translocates from the mitochondria to the nucleus and causes chromosome condensation and large-scale DNA fragmentation. These effects are independent of caspases and the oxidoreductase activity of AIF (Susin et al., 1999; Daugas et al., 2000; Miramar et al., 2001; Cande et al., 2002) . Gene knockout studies suggest that AIF is required for apoptosis of embryonic stem cells induced by serum deprivation, and is essential for apoptosis during cavitation of embryonic bodies (Joza et al., 2001 ). We and others have identified an AIF-homologous flavoprotein called AMID/PRG3 (Ohiro et al., 2002; Wu et al., 2002) . AMID lacks a mitochondrial localization sequence but shares significant homology with AIF and NADH-oxidoreductases from bacteria to mammalian species. Immunofluorescent staining and biochemical experiments suggest that AMID is associated with the outer membrane of mitochondria. Overexpression of AMID induces cell death with characteristic apoptotic morphology and this is independent of caspase activation (Ohiro et al., 2002; Wu et al., 2002) . Furthermore, transcription of human AMID gene is induced by p53 and expression of AMID is significantly downregulated in some tumors in comparison to their matched normal tissues (Ohiro et al., 2002; Wu et al., 2004) . These studies point to the possibility that AMID may be involved in p53-induced downstream effects such as growth arrest or apoptosis and might be a potential tumor suppressor gene.
To investigate the physiological functions of AMID, we have generated AMID-deficient mice. Our results suggest that AMID is not required for normal development and p53-induced downstream effects.
Results
Sequence and expression analysis of mouse AMID We search the GeneBank databases and identified mouse AMID amino-acid sequence. Sequence alignment indicates that mouse and human AMID proteins are highly conserved with B90% identity at amino-acid level ( Figure 1a) . The high homology between human and mouse AMID suggests that AMID has evolutionarily conserved functions.
To determine the expression pattern of mouse AMID gene, we performed Northern blot analysis. The results indicate that mouse AMID mRNA is expressed in most examined tissues as two transcripts of B4.0 and B1.8 kb, respectively. Mouse AMID is expressed at relatively higher levels in liver, testis and kidney, and lower levels in pancreas, spleen, brain and lung (Figure 1b) .
Generation of AMID-deficient mice
To investigate the in vivo functions of AMID, we attempted to disrupt AMID gene in mouse by homologous recombination. Mouse AMID gene fragments were isolated from 129/sv mouse genomic l phage library using a recently developed recombination cloning (REC) method (Zhang et al., 2002) . Targeting strategy for mouse AMID gene is illustrated in Figure 2a . In this strategy, part of exon 2 containing the ATG start codon is replaced by a neomycin resistance cassette (Figure 2a ). The targeting vector was introduced into TC1 ES cell line and two out of 384 G418-, ganciclovir-resistant ES clones were correctly targeted as demonstrated by Southern blot analysis (data not shown). These two heterozygous ES clones were used to generate chimeric and then heterozygous mice. AMID heterozygous mice were interbred to produce homozygous mutant mice. All offspring were genotyped by PCR (data not shown) and Southern blot analysis as illustrated in Figure 2b and c. Northern blot analysis from AMID wild type and homozygous MEFs showed that mutant mouse AMID mRNA was expressed at a lower level with a smaller size compared to its wild-type control (data not shown). We cloned the mutant AMID cDNA by RT-PCR. Sequence analysis indicates that the mutant AMID cDNA lacks the B200 bp fragment of exon 2 as expected. To determine whether the mutant AMID mRNA expresses a truncated protein, we cloned the wild type and mutant AMID cDNAs into a C-terminal Flag-tagged mammalian expression plasmid. Transient transfection and Western blot analysis with Flag antibody indicated that the wild-type AMID cDNA expressed an expected B39 kDa protein while the mutant AMID cDNA did not express any truncated protein at all ( Figure 2d ). These results suggest that deletion of the ATG and nearby sequence of mouse AMID gene caused deficient translation of mouse AMID mRNA. To confirm whether AMID expression is absent in the homozygous mice, we raised a rabbit polyclonal antibody against mouse AMID and performed Western blot analysis. As shown in Figure 2e , AMID is detected in testis, kidney and spleen from only wild type but not AMID À/À mice.
AMID is not required for normal development AMID À/À mice were produced at Mendelian ratios from heterozygous intercrosses and were without any overt abnormal phenotypes up to 1 year old. Both male and female AMID null mice were fertile. The pregnancy rates and litter sizes were similar between wild type and AMID À/À mice. Evaluation of histological sections of tissues expressing higher levels of AMID mRNA, including testis, heart, kidney, and liver, failed to reveal any pathological abnormalities (data not shown). These results suggest that AMID is not required for normal development and functions.
Mouse AMID is induced by genotoxins Previously, it has been shown that human AMID mRNA is transcriptionally induced by p53 and genotoxins (Ohiro et al., 2002; Wu et al., 2002) . We determined whether mouse AMID is also upregulated by genotoxins in MEFs. As shown in Figure 4 , both mouse p53 and AMID protein levels were upregulated in wild-type MEFs following treatment with the genotoxic agents 5-fluorouracil or etoposide. In the same experiments, no AMID expression was detected in AMID À/À MEFs in the presence or absence of the genotoxic agents ( Figure 3 ). These results suggest that AMID is induced by genotoxins in wild-type MEFs.
AMID
À/À MEFs show normal proliferation but increased resistance to genotoxin-induced growth arrest or apoptosis To determine whether AMID plays a role in genotoxininduced growth arrest or apoptosis, we examined whether wild type and AMID À/À MEFs respond differently to genotoxins. In the absence of genotoxins, wild type and AMID À/À MEFs proliferated at similar rates in MTT assays (Figure 4a ). However, AMID À/À MEFs were slightly less sensitive to growth inhibition induced by the genotoxic agents doxorubicin, 5-fluorouracil and etoposide in these assays (Figure 4b-d) . This effect is most significant at day 2 following the drug treatment. Since MTT assay measures the combined result of proliferation and death, we performed annexin V and PI double staining experiments to determine whether wild type and AMID
À/À
MEFs respond differently to genotoxin-induced apoptosis. The results indicated that doxorubicin and 5-fluorouracil did not significantly induce apoptosis of both wild type and AMID À/À MEFs at day 2 following the drug treatment ( Figure 5 ). In the same experiments, etoposide significantly induced apoptosis of both wild type and AMID À/À MEFs. However, the percentage of apoptotic cells had no significant difference in the wild type and AMID À/À MEFs at day 2 after drug treatment ( Figure 5 ). These results suggest that AMID is not involved in genotoxininduced apoptosis but practically contributes to genotoxin-induced growth arrest.
AMID is not a tumor suppressor gene p53 is a tumor suppressor gene and mice homozygous for its null allele are prone to the spontaneous development of a variety of neoplasms by 6 months of AMID knockout studies J Mei et al age (Donehower et al., 1992) . Previous report showed that AMID is downregulated in most examined tumors by expression array analysis, pointing to a possibility that AMID is a novel p53-downstream effecter involved in regulation of tumorigenesis. We did not observe any spontaneous tumors in over 20 AMID À/À mice up to 1 year old (data not shown), and WT and AMID À/À mice showed comparable MCA-induced sarcoma incidence ( Figure 6 ). These results indicate that AMID does not play any critical, nonredundant roles in p53-mediated tumor suppressing effects.
Discussion
Human AMID is a recently identified AIF homologous flavoprotein. Similar to AIF, overexpression of AMID induces caspase-independent apoptosis (Ohiro et al., 2002; Wu et al., 2002) . Expression of AMID is upregulated by p53 and genotoxins and downregulated in tumors in comparison to their matched normal tissues, pointing to the possibility that AMID is involved in p53-mediated apoptotic effect (Ohiro et al., 2002; Wu et al., 2004) . In this study, we generated AMID gene knockout mice in an attempt to investigate the physiological and pathological roles of AMID in vivo. The AMID À/À mice are viable and fertile and display no obvious abnormality up to 1 year old, suggesting that AMID is not required for normal development in mice. This is in sharp contrast with the 
AMID knockout studies
J Mei et al phenotypes of AIF gene disruption in mice. Mouse AIF gene is localized in X chromosomes. It has been shown that early development of AIF À/y embryos is blocked at cavitation due to lack of apoptosis of the inner cells (Joza et al., 2001 ). These observations suggest that AMID is not an obligated component of AIF-induced apoptotic pathway.
p53 is induced by DNA damage and it antagonizes cell transformation through inducing apoptosis, growth arrest and senescence (Hansen and Oren, 1997; Levine, 1997; Giaccia and Kastan, 1998; Prives and Hall, 1999) . The effects of p53 are mediated through induction of a set of downstream genes, such as p21, Apaf-1, NOXA, Bax, BAD, DR5 and PUMA. We and others have shown that transcription of human AMID gene is upregulated by p53 and genotoxins (Ohiro et al., 2002; Wu et al., 2004) . In this study, we show that mouse AMID protein is also upregulated by genotoxic reagents 5-fluorouracil and etoposide in MEFs (Figure 3) . Annexin V and PI double staining experiments suggest that wild type and AMID À/À MEFs respond similarly to apoptosis induced by doxorubincin, 5-fluorouracil and etoposide at day 2 after drug treatment ( Figure 5 ). However, MTT assays indicate that AMID À/À MEFs have slightly increased resistance to growth inhibition induced by these genotoxins (Figure 4 ). These observations suggest that AMID is not involved in genotoxininduced apoptosis but might partially contribute to genotoxin-induced growth arrest. However, it is obvious that growth of AMID À/À MEFs is still inhibited following genotoxin treatment, suggesting that AMID does not play any critical, nonredundant roles in genotoxin-induced growth arrest. Consistent with these observations, AMID À/À mice did not develop spontaneous tumors and had similar MCA-induced sarcoma incidence in comparison with wild-type mice (Figure 6 ). Taken together, our present study suggests that AMID does not play any critical, nonredundant roles in p53-mediated effects.
Materials and methods

Reagents
Monoclonal antibodies against the Flag epitope (Sigma), b-tubulin (Santa Cruz Biotechnology) and p53 (Abcam Inc.) were purchased from the indicated manufacturers. Other chemicals are from Sigma.
Preparation of rabbit polyclonal anti-mouse AMID antibody Mouse AMID cDNA was cloned into the pET30c vector, which was transformed into the BL21 Escherechia coli strain. 
AMID knockout studies J Mei et al
Expression of His6-tagged mouse AMID protein in BL21 was induced with IPTG and purified by a nickel column under denatured condition (Novagen). The purified protein was dialysed against 1 Â PBS solution and subcutaneously injected into two rabbits to produce anti-mouse AMID polyclonal antisera.
Generation of AMID-deficient mice
Recombinant cloning method (Zhang et al., 2002 ) was used to screen for mouse AMID genomic DNA clones from a 129/sv strain genomic lKO-1 library. Two 70 bp homologies as follows were used to screen the lKO-1 library. Homology 1: To make the mouse AMID targeting vector, the tetracycline resistance gene (Tc r ) in one mouse AMID genomic DNA clone with two appropriate arms was replaced with a neomycin cassette. The targeting construct was linearized by PmeI restriction digestion and electroporated into TC1 ES cells (derived from 129Sv mouse strain). These cells were selected for 10 days in medium containing G418 (200 mg/ml) and gancyclovir (2 mM). G418-, gancyclovir-resistant ES cell clones (totally 384) were screened by Southern blot analysis with both the external and internal mouse AMID probes. Two of these clones were found to contain correctly targeted allele, and were injected into C57BL/6 blastocysts to produce chimeric mice. One chimeric male mouse gave germ line transmission of the targeted allele. The heterozygous mice were interbred to obtain homozygous mice.
Histology
Tissues from 4 months old wild-type and AMID-deficient mice were collected and fixed in 10% neutral buffered formalin solution. The tissue samples were embedded in paraffin, sectioned, stained with hematoxylin and eosin, and analysed by light microscopy.
Preparation and culture of MEFs
All MEFs are derived individually from 13.5-day-old embryos in one AMID þ /À female mouse interbred with another AMID þ /À male mouse. Following removal of the head and organs, embryos were rinsed with PBS, minced, and digested with trypsin (0.25% solution containing 2.21 mM EDTA) for 5 min at 371C. Trypsin was inactivated by addition of Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum, 2 mM glutamine, 0.1 mM minimal essential medium nonessential amino acids, 55 mM 2-mercaptoethanol, penicillin (500 IU/ml), and streptomycin (500 mg/ ml). Cells from single embryos were plated into one 100-mm dish and incubated at 371C in a 5% CO 2 humidified chamber. Cells were maintained on a defined schedule (9 Â 10 5 cells per 60-mm dish passaged every 3 days). Plating after disaggregation of embryos was considered to be passage 1. All MEFs from each individual embryos were genotyped by PCR and South blotting.
Northern blot analysis
Total RNA from various tissues was prepared using Trizol reagent (Invitrogen). Total RNA (20 mg/lane) was separated on 1% formaldehyde agarose gel. Mouse AMID cDNA fragment corresponding to its coding sequence was used as probe after being labeled with [a-32 P]dCTP using a random priming labeling kit (Roche). Membranes were hybridized using ExpressHyb hybridization solution (Amersham) and washed under high stringency condition.
Western blot analysis
For transient transfection, 293 cells in six-well plate were transfected for 24 h. Transfected cells were lysed in 0.1 ml of lysis buffer (15 mM Tris, 120 mM NaCl, 1% Triton, 25 mM KCl, 2 mM EGTA, 2 mM EDTA, 0.1 mM dithiothreitol, 0.5% Triton X-100, 10 mg/ml aprotinin, 10 mg/ml leupeptin, and 0.5 mM phenylmethylsulfonyl fluoride, pH 7.5). The lysates were fractionated by SDS-PAGE, and then standard Western blot analysis was performed.
For Western blot analysis of tissue protein samples, tissues were minced in liquid nitrogen, then lysed in 0.5 ml of above lysis buffer and 0.5 ml 2 Â SDS-PAGE sample loading buffer, and boiled for 10 min. 
MTT assays
MTT assay was performed according to previously described method (Mosmann, 1983) . In brief, cells cultured in 96-well plate were incubated with MTT (0.5 mg/ml) for 4 h and then the crystals in each well were dissolved in 0.1 ml isopropanol/ HCl (0.04 N HCl in 2-propanol). The OD of each well was measured on an ELISA plate reader with the wavelength of 570 nm.
Annexin V apoptosis detection assay Wild type and AMID À/À MEFs (passage 4) were seeded in sixwell plate at a density of 1 Â 10 6 cells per well. After 24 h, cells were left untreated, or treated with 40 mg/ml of 5-fluorouracil, 0.2 mg/ml of doxorubicin or 50 mM of etoposide for 2 days. The cells were collected by trypsinization and centrifugation and washed with PBS. The cells were then stained with annexin V and PI in annexin V staining buffer (BD Bioscience) for 5 min at room temperature. The cells were analysed with a FACScan cytometer (Becton-Dickinson, San Jose, CA, USA). Percentage of apoptotic cells was calculated from a total of 10 4 cells using FlowJo 4.5.2 software.
Fibrosarcoma induction by MCA Wild type and AMID
À/À mice with the mixed genetic background (C57Bl/6 Â 129Sv/Ev) were inoculated s.c. in the hind flank with 5, 25, 100, or 400 mg of 3-methylcholanthrene (MCA; Sigma-Aldrich) in 0.1 ml of corn oil. Development of fibrosarcomas was monitored periodically over the course of 80-200 days. Tumors >2 mm in diameter and demonstrating progressive growth were recorded as positive.
